US Broker Ratings

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring a 23% Upside Potential and Robust Free Cash Flow

Emergent BioSolutions Inc. (NYSE: EBS) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered in Gaithersburg,..

Personalis, Inc. (PSNL) Stock Analysis: A Promising 14.46% Upside Potential Amid Strategic Collaboration

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the healthcare sector, specializes in diagnostics and research with a focus on advanced cancer genomic tests. As the..

Treace Medical Concepts, Inc. (TMCI): Investor Outlook Highlights 83.77% Potential Upside

Investors with an interest in the healthcare sector, particularly in medical devices, should keep a keen eye on Treace Medical Concepts, Inc. (NASDAQ: TMCI). This Florida-based..

EyePoint, Inc. (EYPT) Stock Analysis: Exploring the 127.80% Potential Upside in a Challenging Market

Investors with a keen interest in the biotechnology sector might find EyePoint, Inc. (EYPT) an intriguing prospect, particularly given its staggering potential upside of 127.80%. As..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Uncovering a 36.50% Potential Upside in the Diagnostics Sector

Myriad Genetics, Inc. (NASDAQ: MYGN), a key player in the healthcare sector’s diagnostics and research industry, offers investors a compelling opportunity with a potential upside of..

Abivax SA (ABVX) Stock Analysis: A Biotech Gem with 30% Upside Potential

Investors on the hunt for opportunities in the ever-evolving biotechnology sector may find Abivax SA (ABVX) an intriguing prospect. This French biotech company, with a market..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating High Growth with Strategic Caution

Sonida Senior Living, Inc. (SNDA), a key player in the medical care facilities industry, continues to draw attention for its robust revenue growth amidst a challenging..

AxoGen, Inc. (AXGN) Stock Analysis: A Promising 18.51% Potential Upside in the Healthcare Sector

AxoGen, Inc. (NASDAQ: AXGN), a leader in the medical devices industry focused on peripheral nerve regeneration and repair, presents an intriguing opportunity for investors with its..

Humacyte, Inc. (HUMA) Stock Analysis: Exploring a Potential 614% Upside in the Biotech Sector

Humacyte, Inc. (NASDAQ: HUMA), a biotechnology company based in Durham, North Carolina, is making waves in the healthcare sector with its groundbreaking approach to developing implantable..

MeiraGTx Holdings plc (MGTX) Stock Analysis: A Biotech Gem with a 247.85% Upside Potential

For investors looking to capitalize on the burgeoning biotechnology sector, MeiraGTx Holdings plc (NASDAQ: MGTX) offers a compelling opportunity. This clinical-stage gene therapy company, with a..

Autolus Therapeutics (AUTL): A Biotech with a 545% Potential Upside – Investor Outlook

Autolus Therapeutics plc (NASDAQ: AUTL) is making waves in the biotechnology sector with its ambitious pipeline of T cell therapies aimed at treating cancer and autoimmune..

Kamada Ltd. (KMDA) Stock Analysis: Exploring a 58.15% Upside in the Healthcare Space

Kamada Ltd. (NASDAQ: KMDA), a prominent player in the specialty and generic drug manufacturing sector, has recently garnered attention in the investment community for its robust..

Sana Biotechnology, Inc. (SANA) Stock Analysis: Exploring a Potential 86.60% Upside in the Biotech Arena

Sana Biotechnology, Inc. (NASDAQ: SANA), a healthcare sector player specializing in biotechnology, has been garnering attention in the investment community. Headquartered in Seattle, Washington, the company..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Unveiling a Potential 300% Upside in Biotech Investment

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a promising player in the biotech sector, has captured investor attention with its ambitious approach to therapeutic innovation. Headquartered in Watertown,..

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 58% Potential Upside in the Medical Device Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the medical device industry, has been capturing investor attention due to its promising potential upside of 58.33%...

Mind Medicine (MNMD) Stock Analysis: A Biotech Bet with 90.86% Potential Upside

As the biopharmaceutical landscape continues to evolve, Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) offers investors a compelling opportunity to engage with the future of brain health..

Standard BioTools Inc. (LAB) Stock Analysis: Navigating a Challenging Market with Innovative Technologies

Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector’s medical devices industry, is a company that demands the attention of savvy investors. With..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a 751% Upside Potential in Biotech

Cel-Sci Corporation (NASDAQ: CVM) is capturing investor attention with its ambitious approach to cancer treatment and a staggering potential upside of 751.70%, according to analyst ratings...

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Biotech with 94.53% Potential Upside

Rapport Therapeutics, Inc. (RAPP), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is making waves in the biotechnology sector with its promising pipeline focused on central..

Simulations Plus, Inc. (SLP) Stock Analysis: Is There a 15% Upside for This Healthcare Innovator?

Simulations Plus, Inc. (NASDAQ: SLP), a prominent player in the healthcare sector, is making waves with its cutting-edge drug discovery and development software. Renowned for its..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds